Medarova Zdravka 13D and 13G filings for TransCode Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-10 08:00 am Purchase | 2022-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ | Medarova Zdravka | 63 12.700% | 2 (+2.61%) | Filing |
| 2022-12-19 5:33 pm Purchase | 2021-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ | Medarova Zdravka | 61 12.500% | 61 (New Position) | Filing |